![Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/a238bd50-fef2-4b65-a5c6-f72db5d122a1/psp412196-fig-0001-m.jpg)
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague](https://www.ncbi.nlm.nih.gov/books/NBK559690/bin/DART_03-Image002.jpg)
Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague
![Toxics | Free Full-Text | Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology’s (SEAZIT’s) Evaluation of Developmental Toxicity Toxics | Free Full-Text | Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology’s (SEAZIT’s) Evaluation of Developmental Toxicity](https://www.mdpi.com/toxics/toxics-12-00093/article_deploy/html/images/toxics-12-00093-g001-550.jpg)
Toxics | Free Full-Text | Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology’s (SEAZIT’s) Evaluation of Developmental Toxicity
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig7_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253120300718-gr2.jpg)
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect
![Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity](https://pub.mdpi-res.com/vaccines/vaccines-10-00756/article_deploy/html/images/vaccines-10-00756-g001.png?1652268154)
Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig5_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253120300718-gr4.jpg)
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect
![Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S245186542030003X-gr1.jpg)
Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect
How to design a dose-finding study on combined agents: Choice of design and development of R functions | PLOS ONE
![Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121014750-grabsf1.jpg)
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect
![Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-017-0681-z/MediaObjects/12931_2017_681_Fig2_HTML.gif)